Empower Cells, Change Lives

Innovative immuno-therapy company welcomes former President and COO of Celgene AUSTIN, Texas & TORONTO--(BUSINESS WIRE)--Triumvira Immunologics, Inc., a privately held biopharmaceutical company developing a novel platform for engineering T cells to attack cancers,...

Brings 30-years of Experience to Company’s Technology Development and Manufacturing Operations AUSTIN, Texas--(BUSINESS WIRE)--Triumvira Immunologics, a privately held biopharmaceutical company developing a novel platform for engineering T cells to attack cancers,...

Sachs Immuno-Oncology BD&L and Investment Forum and 2018 BIO International Convention AUSTIN, Texas & HAMILTON, Ontario - Triumvira Immunologics, a privately held biopharmaceutical company developing a novel platform for engineering T cells to attack multiple types of...